Allergy Therapeutics Plc - Company Profile

Powered by

All the data and insights you need on Allergy Therapeutics Plc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Allergy Therapeutics Plc Strategy Report

  • Understand Allergy Therapeutics Plc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Allergy Therapeutics Plc: Overview

Select Item

Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers aluminum-free allergy vaccines and diagnostics. Allergy Therapeutics product portfolio includes Grass Modified Allergen Tyrosine Adsorbed (MATA), Tree MATA, Ragweed MATA, Bee Venom Subcutaneous Immunotherapy (SCIT), and Wasp venom SCIT among others. It also offers allergen extracts used for skin prick testing. The company’s diagnostics products comprise Pollen, Moulds, Arthropods, Epithelia and others. It has an operational presence in Germany, Italy, Spain, Austria, Switzerland, the Netherlands and the UK, among others. Allergy Therapeutics is headquartered in Worthing, West Sussex, the UK.

 Gain a 360-degree view of Allergy Therapeutics Plc and make more informed decisions for your business Gain a 360-degree view of Allergy Therapeutics Plc and make more informed decisions for your business Find out more
Headquarters United Kingdom
Address Dominion Way, Worthing, England, BN148SA
Website www.allergytherapeutics.com
Telephone 44 1903 844700
No of Employees 635
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange AGY (LON)
Revenue (2022) $73.4M -18.1% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -212.7% (2022 vs 2021)
Market Cap* $167.8M
Net Profit Margin (2022) XYZ -281.8% (2022 vs 2021)
* As of and is in US$
View Allergy Therapeutics Plc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Allergy Therapeutics Plc premium industry data and analytics

40+

Clinical Trials

Determine Allergy Therapeutics Plc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Allergy Therapeutics Plc’s relevant decision makers and contact details.

17+

Catalyst Calendar

Proactively evaluate Allergy Therapeutics Plc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

15+

Pipeline Drugs

Identify which of Allergy Therapeutics Plc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

9

Marketed Drugs

Understand Allergy Therapeutics Plc’s commercialized product portfolio to stay one step ahead of the market.

3

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

2

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Allergy Therapeutics Plc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Vaccines: Pollinex
Pollen-related Allergies Oralvac
Allergies to Grasses and Trees Tyrosine
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Allergy Therapeutics Plc portfolio and identify potential areas for collaboration Understand Allergy Therapeutics Plc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Allergy Therapeutics Plc Roxall Medizin GmbH Allergopharma GmbH & Co KG Biomay AG HAL Allergy BV
Headquarters United Kingdom Germany Germany Austria Netherlands
City Worthing Oststeinbek Reinbek Vienna Leiden
State/Province England Hamburg Schleswig-Holstein Wien Zuid-Holland
No. of Employees 635 48 - - -
Entity Type Public Private Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Manuel Llobet Chief Executive Officer; Director Executive Board 2009 -
Shaun Furlong Director; Chief Financial Officer Executive Board 2024 -
Peter Jensen Chairman Non Executive Board 2011 -
Karley Cheesman Company Secretary Senior Management 2023 -
Tunde Otulana Director Non Executive Board 2017 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Allergy Therapeutics Plc key executives to enhance your sales strategy Gain insight into Allergy Therapeutics Plc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward